期刊
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
卷 11, 期 -, 页码 -出版社
FRONTIERS MEDIA SA
DOI: 10.3389/fcimb.2021.735394
关键词
COVID-19; pregnancy; lactation; maternal immunization; vaccination; SARS-CoV-2; mRNA vaccine
资金
- Eunice Kennedy Shriver National Institute of Child Health and Human Development [3R01HD100022-02S2, K12HD103096-01]
- Claflin Award from Massachusetts General Hospital Executive Committee on Research
The COVID-19 pandemic has highlighted the urgent need to develop vaccine strategies optimized for pregnant people and their newborns, even though pregnant individuals were not included in vaccine trials but have had access to them since release. The rapid distribution of COVID-19 vaccines to at-risk individuals, including pregnant and lactating women, provides an unprecedented opportunity to understand vaccine-induced immunity in these populations.
The COVID-19 pandemic has demonstrated the urgent need to develop vaccine strategies optimized for pregnant people and their newborns, as both populations are at risk of developing severe disease. Although not included in COVID-19 vaccine development trials, pregnant people have had access to these vaccines since their initial release in the US and abroad. The rapid development and distribution of novel COVID-19 vaccines to people at risk, including those who are pregnant and lactating, presents an unprecedented opportunity to further our understanding of vaccine-induced immunity in these populations. In this review, we aim to summarize the literature to date on COVID-19 vaccination in pregnancy and lactation and highlight opportunities for investigation that may inform future maternal vaccine development and implementation strategies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据